Technical Analysis for ABT - Abbott Laboratories

Grade Last Price % Change $ Change
grade A $45.40 0.87% 0.39
ABT closed up 0.87 percent on Thursday, February 23, 2017, on approximately normal volume. The bulls were able to push the stock to a new 52-week high. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical ABT trend table...

Date Alert Name Type % Chg
Feb 23 New 52 Week High Bullish 0.00%
Feb 22 NR7 Range Contraction 0.87%
Feb 22 Narrow Range Bar Range Contraction 0.87%
Feb 17 Golden Cross Bullish 1.59%
Feb 10 NR7 Range Contraction 6.22%
Feb 10 Narrow Range Bar Range Contraction 6.22%
Feb 8 NR7 Range Contraction 7.08%
Feb 7 New Uptrend Bullish 5.85%
Feb 6 Spinning Top Other 7.00%
Feb 6 Stochastic Sell Signal Bearish 7.00%

Older signals for ABT ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.

Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, pain, fever, inflammation, hypothyroidism, gynecological disorders, intrahepatic cholestasis or depressive symptoms, physiological rhythm of the colon, dyslipidemia, and hypertension, as well as provides anti-infective and influenza vaccines. The company’s Diagnostic Products segment provides diagnostic systems and tests, such as immunoassay and clinical chemistry systems; assays for screening and diagnosis for drugs of abuse, cancer, therapeutic drug monitoring, fertility, and physiological and infectious diseases; genomic-based tests; hematology systems and reagents; and diagnostic systems and tests for blood analysis, as well as instruments that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents. Its Nutritional Products segment offers pediatric and adult nutritional products comprising various forms of prepared infant and follow-on formula. The company’s Vascular Products segment provides coronary, endovascular, vessel closure, and structural heart devices for the treatment of vascular disease. Abbott Laboratories also offers blood glucose monitoring meters, test strips, and data management software and accessories for people with diabetes; and medical devices for the eye, including cataract surgery, LASIK surgery, contact lens care products, and dry eye products. The company primarily serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians’ offices, and government agencies. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.
Is ABT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 45.51
52 Week Low 36.3
Average Volume 9,368,890
200-Day Moving Average 40.63
50-Day Moving Average 40.95
20-Day Moving Average 43.04
10-Day Moving Average 44.05
Average True Range 0.61
ADX 38.22
+DI 42.33
-DI: 9.55
Chandelier Exit (Long, 3 ATRs) 43.68
Chandelier Exit (Short, 3 ATRs) 41.08
Upper Bollinger Band 45.68
Lower Bollinger Band 40.4
Percent B (%b) 0.95
Bandwidth 0.122677